TY  - JOUR
AU  - Lluch, Ana
AU  - Barrios, Carlos H
AU  - Torrecillas, Laura
AU  - Ruiz-Borrego, Manuel
AU  - Bines, Jose
AU  - Segalla, Jose
AU  - Guerrero-Zotano, Ángel
AU  - García-Sáenz, Jose A
AU  - Torres, Roberto
AU  - de la Haba, Juan
AU  - García-Martínez, Elena
AU  - Gómez, Henry L
AU  - Llombart, Antonio
AU  - Bofill, Javier Salvador
AU  - Baena-Cañada, José M
AU  - Barnadas, Agustí
AU  - Calvo, Lourdes
AU  - Pérez-Michel, Laura
AU  - Ramos, Manuel
AU  - Fernández, Isaura
AU  - Rodríguez-Lescure, Álvaro
AU  - Cárdenas, Jesús
AU  - Vinholes, Jeferson
AU  - Martínez de Dueñas, Eduardo
AU  - Godes, Maria J
AU  - Seguí, Miguel A
AU  - Antón, Antonio
AU  - López-Álvarez, Pilar
AU  - Moncayo, Jorge
AU  - Amorim, Gilberto
AU  - Villar, Esther
AU  - Reyes, Salvador
AU  - Sampaio, Carlos
AU  - Cardemil, Bernardita
AU  - Escudero, Maria J
AU  - Bezares, Susana
AU  - Carrasco, Eva
AU  - Martín, Miguel
AU  - GEICAM Spanish Breast Cancer Group
AU  - CIBOMA (Iberoamerican Coalition for Research in Breast Oncology)
AU  - LACOG (Latin American Cooperative Oncology Group)
PY  - 2019
DO  - 10.1200/JCO.19.00904
UR  - http://hdl.handle.net/10668/14792
T2  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
AB  - Operable triple-negative breast cancers (TNBCs) have a higher risk of relapse than non-TNBCs with standard therapy. The GEICAM/2003-11_CIBOMA/2004-01 trial explored extended adjuvant capecitabine after completion of standard chemotherapy in patients...
LA  - en
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - Capecitabine
KW  - Chemotherapy, Adjuvant
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Triple Negative Breast Neoplasms
KW  - Young Adult
TI  - Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
TY  - research article
VL  - 38
ER  -